Cancer BiologybioRxiv
Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance.
C. Alcon, A. Manzano-Munoz, E. Prada…·J. Montero
This study uses dynamic BH3 Profiling to identify BH3 mimetic combinations that enhance chemotherapy efficacy and prevent resistance in rhabdomyosarcoma.
DOI 10.1038/s41419-020-02887-y